[1] Horiuchi K, Umetani M, Minami T, et al. Wilms’ tumor 1-associating protein regulates G2/M transition through stabilization of cyclin A2 mRNA[J]. Proceedings of the national academy of sciences of the united states of america,2006,103(46):17278-17283.
[2] Small T W, Bolender Z, Bueno C, et al. Wilms’ Tumor 1–Associating Protein Regulates the Proliferation of Vascular Smooth Muscle Cells[J]. Circulation Research,2006,99(12):1338-1346.
[3] Horiuchi K, Kawamura T, Iwanari H, et al. Identification of Wilms' Tumor 1-associating Protein Complex and Its Role in Alternative Splicing and the Cell Cycle[J]. Journal of Biological Chemistry,2013,288(46):33292-33302.
[4] Small T W, Pickering J G. Nuclear Degradation of Wilms Tumor 1-associating Protein and Survivin Splice Variant Switching Underlie IGF-1-mediated Survival[J]. Journal of Biological Chemistry,2009,284(37):24684-24695.
[5] Fukusumi Y, Naruse C, Asano M. Wtap is required for differentiation of endoderm and mesoderm in the mouse embryo[J]. Developmental Dynamics,2008,237(3):618-629.
[6] Zhang J, Tsoi H, Li X, et al. Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP–WT1–TBL1 axis[J]. Gut,2016,65(9):1482-1493.
[7] Jo H, Shim H, Han M, et al. WTAP regulates migration and invasion of cholangiocarcinoma cells[J]. Journal of Gastroenterology,2013,48(11):1271-1282.
[8] Jin D, Lee S W, Han M, et al. Expression and roles of Wilms' tumor 1-associating protein in glioblastoma[J]. Cancer Science,2012,103(12):2102-2109.
[9] Chen Y, Peng C, Chen J, et al. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1[J]. Molecular Cancer,2019,18(1).
[10] Li B, Liang Z, Seery S, et al. WT1 associated protein promotes metastasis and chemo-resistance to gemcitabine by stabilizing Fak mRNA in pancreatic cancer[J]. Cancer Letters,2019,451:48-57.
[11] Tang J, Wang F, Cheng G, et al. Wilms’ tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability[J]. Journal of Experimental & Clinical Cancer Research,2018,37(1).
[12] Zhou Z, Licklider L J, Gygi S P, et al. Comprehensive proteomic analysis of the human spliceosome[J]. Nature,2002,6903(419):182-185.
[13] Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis[J]. BMC Bioinformatics,2008,9(559).
[14] Yu G, Wang L, Han Y, et al. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters[J]. OMICS: A Journal of Integrative Biology,2012,16(5):284-287.
[15] Mootha V K, Lindgren C M, Eriksson K, et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes[J]. Nature Genetics,2003,34(3):267-273.
[16] Subramanian A, Tamayo P, Mootha V K, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles[J]. Proc Natl Acad Sci U S A,2005,102(43):15545-15550.
[17] Fekete J T, Qsz Á, Pete I, et al. Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1816 ovarian cancer patients[J]. Gynecologic Oncology,2020,156(3):654-661.
[18] Chandrashekar D S, Bashel B, Balasubramanya S A H, et al. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses[J]. Neoplasia,2017,19(8):649-658.
[19] Zaccara S, Ries R J, Jaffrey S R. Reading, writing and erasing mRNA methylation[J]. Nat Rev Mol Cell Biol,2019,20(10):608-624.
[20] Ping X L, Sun B F, Wang L, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase[J]. Cell Res,2014,24(2):177-189.
[21] Müller S, Glaß M, Singh A K, et al. IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner[J]. Nucleic Acids Research,2019,47(1):375-390.
[22] Liu J, Eckert M A, Harada B T, et al. m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer[J]. Nature Cell Biology,2018,20(9):1074-1083.
[23] Mayya V K, Duchaine T F. Ciphers and Executioners: How 3'-Untranslated Regions Determine the Fate of Messenger RNAs[J]. Front Genet,2019,10:6.
[24] Wang Q, Chen C, Ding Q, et al. METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance[J]. Gut,2019:2019-319639.